Vibrio vulnificus (lactose-positive Vibrio), a recently recognized pathogenic marine species, produced extreme hemoconcentration and death within 3 to 6 h after subcutaneous or intraperitoneal injection of 108 viable cells into mice; hemotocrit values approached 70% (normal, 45%). About 1 ml of edema fluid accumulated at the site of each subcutaneous injection, and locally increased vascular permeability was demonstrated by a skin bluing assay, using Evans blue dye. A corresponding fluid accumulation did not occur in the peritoneal cavity after an intraperitoneal injection. Filter-sterilized supematants of cultures grown under a variety of conditions did not produce local edema or lethality, nor did whole Vibrio cells killed by a variety of methods or disrupted by sonic oscillation. Edema fluids collected from infected mice and sterilized by filtration had no effect when they were injected subcutaneously or intraperitoneally into mice. Inocula of 109 viable cells of V. vulnificus contained within a diffusion chamber implanted subcutaneously did not produce skin bluing, edema, or lethality; Vibrio cells remained viable and virulent within these chambers for at least 2 weeks. These experiments suggested that vascular permeability changes in V. vulnificus infections may not be attributable to a diffusible toxin and may require direct contact between host cells and viable Vibrio cells.
Vibrio vulnificus is a marine Vibrio species
recently recognized as a human pathogen (3, 10) . This organism is phenotypically very similar to Vibrio parahaemolyticus and Vibrio alginolyticus but may be differentiated from those two species by a number of physiological characteristics (3). Hollis et al. (10) vulnificus, as suggested by Farmer (8) .
Deoxyribonucleic acid hybridization studies (6, 13) have shown that V. vulnificus strains are highly related to each other and distinct from other Vibrio species, including V. parahaemolyticus and V. alginolyticus. Unlike the latter two species, V. vulnificus produces rapidly progressive wound infections and frequently is isolated from the blood of patients. The clinical and epidemiological features of 39 cases of V.
vulnificus infection have been reviewed by Blake et al. (4) . Two clinical forms of the disease are recognized. One is fulminating septicemia, in which V. vulnificus is isolated from blood cultures and sometimes also from secondary skin lesions. The apparent portal of entry is the gastrointestinal tract, and an association has been made with consumption of raw oysters. This form of infection occurs primarily in patients with preexisting hepatic disease; 4 We have observed that extreme hemoconcentration accompanies edema in mice infected with V. vulnificus and undertook the experiments described here to investigate whether an extracellular toxin might be the basis for the massive loss of intravascular fluid which characterizes this type of infection in the mouse model. Although this study verified hemoconcentration and edema in mice injected with V. vulnificus, we were not able to demonstrate the presence of a toxin responsible for these effects.
MATERIALS AND METHODS Cultures. Centers for Disease Control strains B3547 and C7184 were provided by R. E. Weaver and D. G. Hollis. Strain C7184 is a human blood isolate; strain B3547 was isolated originally from the gangrenous leg of a septic patient described by Roland (14) . The latter strain was included in previous taxonomic (3) and deoxyribonucleic acid-deoxyribonucleic acid reassociation (6, 13) studies; both of these strains were used by Poole and Oliver (12) Visualization of local edema. The lumbar area of the back of each mouse was depilated with Nair (Carter Products, New York, N.Y.), washed thoroughly with tap water, and allowed to dry. Immediately before s.c. injection of Vibrio cells or of saline, these mice were injected i.p. with 0.5 ml of Evans blue (0.5% aqueous solution), which enters the vascular system and binds to albumin (15 Testing of nonviable materials. The massive edema observed after s.c. injection and the hemoconcentration which developed after s.c. or i.p. injection suggested the possible involvement of a toxin that acted to increase vascular permeability. Therefore, we tested broth supernatants, killed cells, and freshly disrupted cells of V. vulnificus for the ability to produce edema or mortality when injected into mice (Table 1) . No preparation other than viable bacteria had any effect on the mice.
Three different filter materials were used for sterilization ofsupernatants to minimize the possibility that a toxin might have been removed by adsorption of the filters (Table 1) .
Many marine Vibrio species produce inducible coilagenases (11) , and such enzymes were considered as possible candidates for an edemaproducing toxin. Various nutritional manipulations were suggested by this possibility, as well as by the conditions found optimal (9) for enterotoxin production in Escherichia coli. Gilligan
and Robertson reported that heat-stable enterotoxin was not produced in the presence of glucose, whereas heat-labile enterotoxin was pro- incubated in brain heart infusion or modified salt water yeast extract broth for 6 or 18 h at 350C or at room temperature with or without shaking. Cultures were centrifuged at 10,000 x g for 20 min, and supernatants were sterilized by filtration and tested immediately in two to five mice. Preparations were injected s.c. (0.1 ml) or i.p. (0.5 ml). Some were also tested intravenously (0.1 ml). The Evans blue method was used with most s.c. injections.
bSupernatants were sterilized by filtration through 0.22-,Im Millipore cellulose acetate filters. All brain heart infusion broth supernatants were also tested after filtration through polycarbonate (Nuclepore Corp., Pleasanton, Calif.) or Teflon (Tuffryn) filters (pore size, 0.45,um).
'The filtrates described in footnote b were concentrated 10-fold by using a PM-10 membrane (Amicon Corp., Lexington, Mass.).
d A filtrate from a brain heart infusion broth-grown culture was concentrated as described in footnote c and then subjected to Sephadex G-100 chromatography as described by Sandefur and Peterson (16) .
'Cells were cultured in modified salt water yeast extract or brain heart infusion broth supplemented (in separate experiments) with the following: 2.5% NaCl; 1% agar; 4% gelatin; 5% sheep erythrocytes; 0.35% pooled human serum; 0.2% collagen, chondroitin sulfate, or hyaluronic acid (Sigma); fresh mouse tendon, skin, or intestine; 0.9% rat liver homogenate; or 1% yeast extract. Cells also were cultured in casein hydrolysate salts medium containing varying concentrations of glucose and NaCl, as follows: glucose, 0 or 1%; NaCl, 0.1, 1.0, or 3.0%. These cultures were incubated at 35°C for 5 or 18 h, sterilized by cellulose acetate membrane filtration (Millipore), and then tested before and after 25-fold concentration (Amicon PM-10 membrane).
fThe pH was adjusted at 24 h from 5.8 to 8.0 or was maintained between 7.2 and 7.9 during growth by periodic addition of dilute NaOH.
" Cells grown in 1.5 liters of brain heart infusion broth supplemented with an additional 2.5% NaCl (shaken overnight at 350C) were harvested by centrifugation and then suspended in 100 ml of 0.12 M tris(hydroxymethyl)aminomethane (pH 8.5). This suspension was incubated at 350C for 2 h and centrifuged, and the supernatant was precipitated with (NH4)2SO4 (90% saturation) overnight at 40C. The precipitate was dissolved in 5 ml of phosphate-buffered saline (pH 7.4) and dialyzed overnight against four changes of 0.1 M sodium phosphate buffer (pH 7.0). h As described in footnote g (from a culture grown in brain heart infusion broth supplemented with an additional 2.5% NaCl without pH release).
i Sterility testing in each case was carried out by plating onto brain heart infusion agar supplemented with an additional 2.5% NaCl. Viable cells which were from the same suspension and were treated identically except for the inactivation step were used as controls in each experiment.
i Groups of 10 (9) . However, these and other variations in media and incubation conditions (Table 1) did not result in demonstrable toxin production by V. vulnificus.
The pH of brain heart infusion broth cultures of V. vulnificus after 24 h of incubation was 5.8. Like cholera toxin, the heat-labile enterotoxin of E. coli remains cell associated below pH 7.0 and is released when the medium pH is readjusted to 8.0 (9). However, attempts at "pH release" did not render V. vulnificus filtrates toxic (Table   1 ).
Sandefur and Peterson (16) described a skin permeability factor produced by Salmonella typhimurium which was detectable only after elution from a Sephadex G-100 column or, to a lesser extent, after concentration by ultrafiltration. These techniques were also tested in our system but had no effect (Table 1) .
The failure of cells killed by a variety of methods and of crude cell extracts prepared by sonic disruption to induce vascular permeability implied that the effect was probably not attributable to endotoxin or other cell-associated products per se. The presence of an inducible cellassociated enzyme, as described by Drzeniek et al. (7) for Pasteurella multocida, is possible.
Collection of edema fluid. Because no vascular permeability factor was evident in culture filtrates or in cells grown in vitro and killed by a variety of methods, we investigated the possibility that a toxin might be elaborated only during in vivo growth. The edema which formed after s.c. injection of V. vulnificus consisted of a gelatinous mass beneath the skin, from which only small amounts of fluid could be collected by prodding with a pipette after the mouse was sacrificed and the skin was dissected away. To obtain sufficient edema fluid for this study, we used helical chambers of surgical steel wire implanted s.c. under ether anesthesia by the method of Arko (1). Such chambers were inserted by twisting through a single needle hole, produced minimal trauma, and provided a space for s.c. fluid accumulation. Mice were used for experiments 3 and 14 days after insertion of chambers. When viable cells of V. vulnificus were injected percutaneously into these chambers, visible edema formed in the surrounding tissues, and fluid accumulated inside the chambers. Such infections were fatal and had time courses similar to the time course after direct s.c. injection. The amounts of fluid obtainable from infected chambers by using a syringe and needle 4 to 5 h after injection of 108 CFU per mouse were eightfold greater than the amounts of fluid obtained from control chambers injected with saline (mean, 0.54 ml from 15 infected mice; mean, 0.07 ml from 9 controls). As observed by phase-contrast microscopy, fluid from infected mice contained large numbers of motile Vibrio cells. Viable counts of 3 x 108 cells per ml were obtained in the chamber fluids withdrawn at death from mice injected with 107 cells. Pooled chamber fluid from infected mice was sterilized by filtration and did not produce edema or skin bluing when it was injected s.c. (0.1 ml) into mice, nor were any symptoms observed after i.p. injection of 0.5 ml.
Immunization studies. It was possible that a toxin might be produced in vivo in amounts too small to produce visible effects after passive transfer. We investigated the possibility that such a product might nevertheless immunize recipient mice against subsequent challenge. At 3-to 4-day intervals, groups of 10 mice received four i.p. injections of 0. chambers remained viable for weeks without producing visible skin bluing or palpable edema suggests that actual contact of Vibrio cells with host tissue may be required to produce these effects; whether a permeability factor is elaborated by the Vibrio or by the host is not known.
As Carpenter (5) has pointed out, the rapidly progressive invasion associated with V. vulnificus infections in both of its recognized clinical forms is unique among Vibrio species, and the pathogenic mechanisms remain to be elucidated. The mouse model studied here is similar in several respects to the infection described in humans. Rapid progression in s.c. tissue with associated edema and subsequent necrosis are characteristic of both systems. Blake et al. (4) pointed out that death in human V. vulnificus infections "appeared to be caused by intractable shock secondary to gram-negative sepsis;" in some patients, thrombocytopenia and the presence of fibrin split products were reported, suggesting disseminated intravascular coagulation. The hemoconcentration and apparent loss of intravascular fluid observed in the mouse model may be interpreted as "shock." Mice dying of V. vulnificus infections appear to die from inadequate tissue perfusion; they appear cyanotic, and eventually breathing ceases, although the heart continues to contract for some time.
Our results with small inocula, immunized mice, and antibiotic therapy demonstrate that under some conditions virulent V. vulnificus can produce mild edema without irreversible progression to lethality. Whether the difference is solely in the extent of intravascular fluid loss or whether systemic invasion or other mechanisms are also required for lethality is not yet clear. One strain of V. vulnificus, CDC-A1402 (a corneal ulcer isolate), was reported by Poole and Oliver to be avirulent in mice. We have observed that this strain is capable of producing mild local edema and bluing but is not lethal after s.c. injection of 109 CFU/mouse. A comparison of this strain with more virulent strains with respect to possible virulence determinants would be of interest and is in progress in our laboratory.
